Structure and Function of the Nuclear Receptor Superfamily and Current Targeted Therapies of Prostate Cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• The nuclear receptor superfamily is a large group of proteins crucial for cell signaling, survival, and proliferation.
• These receptors function as transcription factors, and their dysregulation is implicated in numerous diseases.
• Targeting nuclear hormone receptors is a viable strategy for cancer therapy due to ligand availability.

Purpose of the Study:

• To review the classification, structure, and function of nuclear receptors.
• To discuss the therapeutic potential and challenges of targeting nuclear receptors in diseases like prostate cancer.
• To explore alternative transcription factor targets, such as signal transducer and activator of transcription (STAT) proteins, for late-stage cancers.

Main Methods:

• Literature review of nuclear receptor superfamily classification and function.
• Analysis of therapeutic strategies targeting nuclear receptors.
• Exploration of alternative transcription factor targets outside the nuclear receptor superfamily.

Main Results:

• Nuclear receptors are classified based on structural and functional differences, acting as critical transcription factors.
• Dysregulation of nuclear receptors is a hallmark of many diseases, with androgen receptor being a key target in prostate cancer.
• Hormone insensitivity in late-stage cancers necessitates exploring alternative targets like STAT proteins.

Conclusions:

• Understanding the structural and functional regulation of nuclear receptors is vital for developing effective therapies.
• Targeting nuclear receptors offers a feasible therapeutic approach, but challenges like hormone insensitivity exist.
• Exploring transcription factors beyond the nuclear receptor superfamily, such as STATs, presents a promising avenue for treating advanced cancers.